These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27493353)

  • 21. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Rojas-Reyes MX; Morley CJ; Soll R
    Cochrane Database Syst Rev; 2012 Mar; (3):CD000510. PubMed ID: 22419276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally invasive surfactant therapy
    Elbaz Y; Portnov I; Lurie-Marcu B; Shinwell ES
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6802-6806. PubMed ID: 34024234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early nasal continuous positive airway pressure versus INSURE in VLBW neonates.
    Saianda A; Fernandes RM; Saldanha J
    Rev Port Pneumol; 2010; 16(5):779-95. PubMed ID: 20927494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactants in the management of respiratory distress syndrome in extremely premature infants.
    Ramanathan R
    J Pediatr Pharmacol Ther; 2006 Jul; 11(3):132-44. PubMed ID: 23118650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future.
    Jeon GW
    Korean J Pediatr; 2019 May; 62(5):155-161. PubMed ID: 30744318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of surfactants in 2009.
    Sweet DG; Halliday HL
    Arch Dis Child Educ Pract Ed; 2009 Jun; 94(3):78-83. PubMed ID: 19460896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress Syndrome.
    Ricci F; Catozzi C; Murgia X; Rosa B; Amidani D; Lorenzini L; Bianco F; Rivetti C; Catinella S; Villetti G; Civelli M; Pioselli B; Dani C; Salomone F
    PLoS One; 2017; 12(1):e0169190. PubMed ID: 28060859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent clinical trials of surfactant treatment for neonates.
    Halliday HL
    Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant-deficient newborn piglet RDS model.
    Rey-Santano C; Mielgo VE; Gomez-Solaetxe MA; Salomone F; Gastiasoro E; Loureiro B
    Pediatr Pulmonol; 2019 May; 54(5):644-654. PubMed ID: 30775857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The minimal invasive surfactant therapy: experience from a low resource setting.
    Ajanwaenyi J; Bamidele O; Osim C; Salami O; Umukoro C; Idaboh T; Chimah U; Okolo A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5177-5183. PubMed ID: 33491516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.